Skip to main content
Explore URMC

Steven M. Silverstein, Ph.D.

Contact Information

Phone Numbers

Office: (585) 275-6742

Faculty Appointments


Professional Background

Dr. Steven Silverstein is a Professor of Psychiatry, Neuroscience, and Ophthalmology at the University of Rochester Medical Center and a member of the Center for Visual Science. He is also the George L. Engel Professor of Psychosocial Medicine, the Associate Chair for Research in Psychiatry, and the Director of the Center for Retina and Brain. He is the former President of the Society for Research in Psychopathology (2017) and the former Chair of the American Psychological Association’s Task Force on Serious Mental Illness (2007-2009). Dr. Silverstein received his Ph.D. in Psychology from the State University of New York at Buffalo in 1989 and completed his internship and fellowship at Cornell Medical College from 1988-1990. His research interests are in: 1) risk factors for serious mental illness and treatment of first-episode psychosis; 2) retinal, perceptual (visual), and cognitive changes in people with schizophrenia, and rehabilitation of those impairments; 3) retinal biomarkers of changes in brain and cognitive functioning in other conditions affecting the brain (e.g., heart failure, cerebral small-vessel disease, sports-related concussion); and 4) mental health issues related to vision loss, and their treatment; He has over 270 publications related to schizophrenia and these other issues. Dr. Silverstein has had continuous grant support since 1991 and is currently principal investigator on several NIH-, industry-, and foundation-funded grants. He has received many awards for his research, clinical, and teaching activities, including the United States Psychiatric Rehabilitation Association’s Armin Loeb Award for research in psychiatric rehabilitation (2008), the New Jersey Psychological Association’s Distinguished Researcher Award (2009), the American Psychological Foundation’s Alexander Gralnick Research Investigator Prize (2010), the Norman H. Edelman Clinical Science Mentorship Award from Rutgers-Robert Wood Johnson Medical School (2010), and the Trailblazer Award from the Schizophrenia Special Interest Group of the Association for Advancement in Behavioral and Cognitive Therapies (2016). He has also mentored several generations of clinicians and researchers who have gone on to successful careers in the area of mental health conditions and their treatment.



BA | Brandeis University

PhD | University at Buffalo, The State University of New York
Clinical Psychology

Post-doctoral Training & Residency

07/1989 - 06/1990
Post-doctoral fellowship, specialization in child psychiatry, Department of Psychiatry, The New York Hospital Cornell Medical Center, New York, NY

07/1988 - 06/1989
Internship in clinical psychology, Department of Psychiatry, The New York Hospital-Cornell Medical Center, New York, NY


SAMHAJ Professional Award
Sponsor: National Alliance of Mental Illness New Jersey

New Jersey Provider Recognition Award
Sponsor: National Alliance of Mental Illness New Jersey Chapter
Location: North Brunswick, NJ

2017 - 2018
Outstanding Provider Award, Chinese American Mental Health Outreach Program
Sponsor: National Alliance of Mental Illness New Jersey Chapter

Schizophrenia Special Interest Group Trailblazer Award
Sponsor: Association for Behavioral and Cognitive Therapies
Location: New York City, NY

Visiting Professorship Award (Jagiellonian University)
Sponsor: Science-Environment-Technologies Project
Location: Krakow, Poland

Norman H. Edelman Clinical Science Mentorship Award
Sponsor: Rutgers Robert Wood Johnson Medical School
Location: Newark, NJ

Alexander Gralnick Research Investigator Prize
Sponsor: American Psychological Foundation

VIEW ALL expand_more

Clinical Trials

Assessment of ERG Components to Discriminate Between Schizophrenia and Bipolar Disorder Type I

Lead Researcher: Steven M Silverstein

This study will further assess electroretinogram (ERG) components obtained with different ERG devices, to be considered in a prediction model for each diagnosis. The prediction models are diaMentis proprietary software used as an ERG-based diagnostic test (classified as a Software as a Medical Device, SaMD) to support the diagnosis of schizophrenia and bipolar disorder type I. They involve the processing and analysis of specific retinal biosignatures (RSPA) with the support of statistical and mathematical modelling processes e.g. machine learning and statistical learning.

View Study Details

A survey of emotional reactions to visual challenges,,A survey of emotional reactions to visual challenges

Lead Researcher: Steven M Silverstein

You will be asked to complete 3 surveys online that will take about a total of 25-30 minutes to complete. The surveys will ask questions about how you have adjusted to your vision loss, as well as the effects of vision loss on your mood, anxiety, and quality of life.

View Study Details


Journal Articles

Keane BP, Erlikhman G, Serody M, Silverstein SM. "A brief psychometric test reveals robust shape completion deficits in schizophrenia that are less severe in bipolar disorder." Schizophrenia research.. 2021 Dec 30; 240:78-80. Epub 2021 Dec 30.

Silverstein SM, Sörensen S, Sunkara A, Lai A, Fradkin SI, Ramchandran RS. "Association of vision loss and depressive symptomatology in older adults assessed for ocular health in senior living facilities." Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists).. 2021 Aug 12; Epub 2021 Aug 12.

Guterman Y, Ataria Y, Silverstein SM. "The Imbalanced Plasticity Hypothesis of Schizophrenia-Related Psychosis: A Predictive Perspective." Cognitive, affective & behavioral neuroscience.. 2021 May 28; Epub 2021 May 28.